keyword
https://read.qxmd.com/read/38653365/no-effect-of-liraglutide-on-high-density-lipoprotein-apolipoprotein-ai-kinetics-in-patients-with-type-2-diabetes
#21
JOURNAL ARTICLE
Laurence Duvillard, Jean-Paul Pais de Barros, Alexia Rouland, Isabelle Simoneau, Damien Denimal, Benjamin Bouillet, Jean-Michel Petit, Bruno Vergès
AIM: The catabolism of high density lipoprotein (HDL) apolipoprotein AI (apoAI) is accelerated in patients with type 2 diabetes (T2D), related to hypertriglyceridemia, insulin resistance and low plasma adiponectin levels. Since liraglutide is likely to partly correct these abnormalities, we hypothesized that it might have a beneficial effect on HDL apoAI kinetics in patients with T2D. METHODS: An in vivo kinetic study of HDL apoAI was performed in 10 patients with T2D before and after 6 months of treatment with 1...
April 21, 2024: Diabetes & Metabolism
https://read.qxmd.com/read/38653281/intra-arterial-chemotherapy-for-retinoblastoma-15-year-experience
#22
JOURNAL ARTICLE
Christina Stathopoulos, Guillaume Saliou, Alexandre Moulin, Maja Beck-Popovic, Francis Munier
No abstract text is available yet for this article.
April 2024: Klinische Monatsblätter Für Augenheilkunde
https://read.qxmd.com/read/38652815/fraction-dose-escalation-of-hypofractionated-radiotherapy-with-concurrent-chemotherapy-and-subsequent-consolidation-immunotherapy-in-locally-advanced-non-small-cell-lung-cancer-a-phase-1-study
#23
JOURNAL ARTICLE
Rui Zhou, FangJie Liu, HongMei Zhang, DaQuan Wang, PengXin Zhang, ShiYang Zheng, YiMei Liu, Li Chen, JinYu Guo, YingYi Zou, Yu-Ming Rong, Hui Liu, Bo Qiu
PURPOSE: This phase 1 trial aimed to determine the maximum tolerated fraction dose (MTFD) of hypofractionated radiotherapy (hypo-RT) combined with concurrent chemotherapy and subsequent consolidation immune checkpoint inhibitors (cICI) for patients with locally advanced non-small cell lung cancer (LA-NSCLC). PATIENTS AND METHODS: Split-course hypo-RT and hypo-boost combined with concurrent chemotherapy were administered at three dose levels (DLs), using a stepwise dose-escalation protocol...
April 23, 2024: Clinical Cancer Research
https://read.qxmd.com/read/38652451/short-term-effects-of-small-volume-saline-infusion-on-acid-base-equilibrium-in-critically-ill-patients
#24
JOURNAL ARTICLE
Davide Chiumello, Tommaso Pozzi, Giulia Catozzi, Mara Chioccola, Federico Cucinotta, Silvia Coppola
BACKGROUND: Short-term acid-base effects of 0.9% saline solution infusion are not well described. Aim of this study was to assess the effects of a fluid challenge with 0.9% saline in critically ill patients according to the Stewart's approach, which allows a precise determination of acid base equilibrium. METHODS: In 40 mechanically ventilated critically ill patients, acid-base variables according to Stewart's approach were measured before and after 30 minutes from the infusion of 0...
April 2024: Minerva Anestesiologica
https://read.qxmd.com/read/38652054/car-t-therapy-followed-by-hematopoietic-stem-cell-transplantation-can-improve-survival-in-children-relapsed-refractory-philadelphia-chromosome-positive-b-cell-acute-lymphoblastic-leukemia
#25
JOURNAL ARTICLE
Yao Li, Guan-Hua Hu, Lan-Ping Xu, Xiao-Hui Zhang, Kai-Yan Liu, Pan Suo, Yu Wang, Yi-Fei Cheng, Xiao-Jun Huang
BACKGROUND: Philadelphia chromosome (Ph)-positive B-cell acute lymphoblastic leukemia (ALL) has a high complete remission (CR) rate, but relapse and prolonged measurable residual disease remain serious problems. We sought to describe the CR rate measurable residual disease negative rate and address the results and safety of pediatric patients who underwent after receiving chimeric antigen receptor (CAR) specific for CD19 (CAR-19) followed by hematopoietic stem cell transplantation (HSCT) for the treatment of Ph-positive ALL...
April 23, 2024: Journal of Pediatric Hematology/oncology
https://read.qxmd.com/read/38651976/plain-language-summary-of-the-karmma-3-study-of-ide-cel-or-standard-of-care-regimens-in-people-with-relapsed-or-refractory-multiple-myeloma
#26
REVIEW
Paula Rodriguez-Otero, Sikander Ailawadhi, Bertrand Arnulf, Krina Patel, Michele Cavo, Ajay K Nooka, Salomon Manier, Natalie Callander, Luciano J Costa, Ravi Vij, Nizar J Bahlis, Philippe Moreau, Scott R Solomon, Michel Delforge, Jesus Berdeja, Anna Truppel-Hartmann, Zhihong Yang, Linda Favre-Kontula, Fan Wu, Julia Piasecki, Mark Cook, Sergio Giralt
WHAT IS THIS SUMMARY ABOUT?: This plain language summary describes the results of a Phase 3 study called KarMMa-3. In this ongoing study, researchers looked at a relatively new treatment for people with multiple myeloma, a type of blood cancer, whose cancer got worse despite treatment (refractory) or had cancer that at first improved with treatment, but eventually stopped responding (relapsed). HOW WAS THIS STUDY CONDUCTED?: In the KarMMa-3 study, people with relapsed or refractory multiple myeloma received either a one-time infusion of a new treatment, named ide-cel, or one of the standard of care regimens currently available for patients with this cancer...
April 23, 2024: Future Oncology
https://read.qxmd.com/read/38651828/the-efficacy-and-safety-of-direct-oral-anticoagulants-in-the-treatment-of-the-acute-phase-of-heparin-induced-thrombocytopenia-a-systematic-review
#27
JOURNAL ARTICLE
Cooper Sadowski, Justin P Reinert
DISCLAIMER: In an effort to expedite the publication of articles, AJHP is posting manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time. PURPOSE: To investigate the safety and efficacy of direct oral anticoagulants (DOACs) in the treatment of the acute phase of heparin-induced thrombocytopenia (HIT)...
April 23, 2024: American Journal of Health-system Pharmacy: AJHP
https://read.qxmd.com/read/38651796/persistent-cytopenia-after-cd19-car-t-therapy-in-relapsed-refractory-dlbcl-patients-could-be-a-predictor-of-efficacy-and-side-effects
#28
JOURNAL ARTICLE
Jingyi Li, Juan Mu, Jia Wang, Xin Li, Qing Li, Yili Jiang, Rui Cui, Qi Deng
Hematological toxicity is a severe adverse event (AE) in anti-CD19 chimeric antigen receptor (CAR) T cell therapy for relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL). However, the pathophysiological mechanism underlying prolonged cytopenia and the relationship between persistent cytopenia, efficacy, and AEs after anti-CD19 CAR T cell therapy are unknown. Therefore, this study explored whether persistent cytopenia after anti-CD19 CAR T cell therapy in patients with R/R DLBCL can predict therapeutic efficacy and AEs...
2024: Cell Transplantation
https://read.qxmd.com/read/38651541/hemodynamics-of-low-pressure-cardiac-tamponade-an-illustrative-case-report
#29
Rasmey Thach, Robert Blank, Charles Lin
A 55-year-old male with acute pericarditis presented with low-pressure cardiac tamponade (LPCT) unresponsive to volume infusion. Subsequent pericardiocentesis resulted in hemodynamic improvement and unmasking of pericardial constriction. This case provides illustrative hemodynamic tracings of LPCT. Additionally, the presence of concurrent pericardial constriction that may indicate a plausible underlying mechanism for the blunted responsiveness to fluid expansion in LPCT. The underlying physiologic processes and the associated hemodynamic tracings are discussed...
April 23, 2024: Catheterization and Cardiovascular Interventions
https://read.qxmd.com/read/38651280/hepatic-artery-infusion-chemotherapy-combined-with-the-folfox-regimen-for-the-treatment-of-hepatocellular-carcinoma-recent-advances-and-literature-review
#30
REVIEW
Suqi Zhu, Yahan Yu, Mingqi Yang, Xin Liu, Mingkai Lai, Jieren Zhong, Xiaoguang Zhao, Ligong Lu, Yanyan Liu
INTRODUCTION: The incidence of primary liver cancer (PLC) has experienced a significant global increase, primarily attributed to the rise in hepatocellular carcinoma (HCC). Unfortunately, HCC is often diagnosed in advanced stages, leaving patients with limited treatment options. Therefore, transformation therapy is a crucial approach for long-term survival and radical resection in patients with advanced HCC. Conversion therapy has demonstrated promise in the treatment of advanced HCC...
April 23, 2024: Expert Review of Anticancer Therapy
https://read.qxmd.com/read/38651070/commentary-the-effects-of-perioperative-dexmedetomidine-infusion-on-hemodynamic-stability-during-laparoscopic-adrenalectomy-for-pheochromocytoma-a-randomized-study
#31
COMMENT
Beibei Zhang, Xiaodong Wang, Yingchao Guan, Minghao Chen
No abstract text is available yet for this article.
2024: Frontiers in Medicine
https://read.qxmd.com/read/38650992/primary-catastrophic-antiphospholipid-syndrome-in-children-with-midbrain-infarction-a-case-report
#32
Qinghua Dong, Jianyun Yin, Hang Su, Qian Ni
BACKGROUND: Catastrophic antiphospholipid syndrome (CAPS) is a multi-system autoimmune disease characterized by extensive thrombosis. Pediatric CAPS is extremely rare and associated with a high mortality rate, especially when midbrain infarction is involved. Hence, early diagnosis and prompt initiation of appropriate treatment for CAPS complicated by midbrain infarction are of utmost importance in achieving favorable outcomes. CASE PRESENTATION: In this report, we present the case of a 14-year-old girl who presented with neurological symptoms and digestive system infection and was initially diagnosed with an "intracranial infection"...
2024: Frontiers in Pediatrics
https://read.qxmd.com/read/38650990/efficacy-and-safety-of-empiric-treatment-with-omeprazole-continuous-infusion-in-critically-ill-children-with-gastrointestinal-bleeding
#33
JOURNAL ARTICLE
Khalid W Taher, Rahaf Yaseen, Mayas Alnan, Wejdan Aburas, Hala Khalil, Moath Alabdulsalam
INTRODUCTION: Gastrointestinal bleeding (GI) is a prevalent condition among pediatric patients, with a reported incidence of 6.4%, often severe enough to require admission to the pediatric intensive care unit (PICU). There are multiple therapies utilized in the management of GI bleeding in pediatrics, among which continuous intravenous (IV) infusion of omeprazole is used off-label without standard pediatric dosing recommendations. Reviewing the current literature reveals a lack of studies assessing the efficacy, safety, and appropriate dosing regimen of continuous omeprazole infusion in children with GI bleeding...
2024: Frontiers in Pediatrics
https://read.qxmd.com/read/38650937/phenotypic-comparison-and-the-potential-antitumor-function-of-immortalized-bone-marrow-derived-macrophages-ibmdms
#34
JOURNAL ARTICLE
Dong-Kun Xie, Jin Yao, Peng-Hui Li, Yan-Wen Zhu, Jia-Nuo Chen, Xiu-Li Cao, Shi-Lin Cheng, Ya-Miao Chen, Yi-Fei Huang, Liang Wang, Zan-Han Wang, Rong Qiao, Jia-Mei Ge, Huan Yue, Li Wei, Zhong-Yuan Liu, Hua Han, Hong-Yan Qin, Jun-Long Zhao
INTRODUCTION: Macrophages are an important component of innate immunity and involved in the immune regulation of multiple diseases. The functional diversity and plasticity make macrophages to exhibit different polarization phenotypes after different stimuli. During tumor progression, the M2-like polarized tumor-associated macrophages (TAMs) promote tumor progression by assisting immune escape, facilitating tumor cell metastasis, and switching tumor angiogenesis. Our previous studies demonstrated that functional remodeling of TAMs through engineered-modifying or gene-editing provides the potential immunotherapy for tumor...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38650520/impact-of-omitting-the-intravenous-heparin-bolus-on-outcomes-of-leadless-pacemaker-implantation
#35
JOURNAL ARTICLE
Jingwen Huang, Neal K Bhatia, Michael S Lloyd, Stacy Westerman, Anand Shah, David Delurgio, Anshul M Patel, Christine Tompkins, Mikhael F El-Chami, Faisal M Merchant
BACKGROUND: Early guidance recommended a bolus of intravenous heparin at the beginning of leadless pacemaker (LP) implantation procedures. However, due to concern about bleeding complications, more recent practice has tended toward omitting the bolus and only running a continuous heparin infusion through the introducer sheath. The impact of omitting the heparin bolus on procedural outcomes is not clear. METHODS: We reviewed all Medtronic Micra LP implants at our institution from 9/2014 to 9/2022...
April 23, 2024: Journal of Cardiovascular Electrophysiology
https://read.qxmd.com/read/38650344/a-comparative-in-vitro-analysis-of-various-temporization-materials-with-respect-to-pulp-chamber-temperature-changes-during-polymerization
#36
JOURNAL ARTICLE
Sneha Bharadwaj, Gopal Krishna Choudhury, Abhilash Mohapatra, Sangram Panda, Upasana Dhar
AIM: (1) To compare the temperature rise in the pulp chamber with different resin materials used for making provisional fixed partial dentures in anterior and posterior region while using Polyvinylsiloxane impression materials as matrix. (2) To identify a superior provisionalization material based on the amount of heat dissipated suitable for anterior and posterior provisional fixed partial denture fabrication. SETTINGS AND DESIGN: Temporary crowns and bridges are integral to Fixed Prosthodontics...
April 1, 2024: Journal of Indian Prosthodontic Society
https://read.qxmd.com/read/38649870/necrotising-fasciitis-with-extensive-necrosis-caused-by-lactobacillus-a-case-report
#37
JOURNAL ARTICLE
Jun Nagayama, Takeo Sato, Ishida Takanori, Koga Kouji, Nakamura Mitsunobu
BACKGROUND: Necrotising fasciitis (NF) is a life-threatening soft-tissue infection that rapidly destroys the epidermis, subcutaneous tissue, and fascia. Despite their low virulence, Lactobacillus spp. can cause NF, and because of its rare incidence, there is limited information about its molecular and clinicopathological characteristics. We report a rare case of NF in a patient with type 2 diabetes mellitus diagnosed on admission and severe obesity due to infection with two types of Lactobacillus spp...
April 22, 2024: BMC Infectious Diseases
https://read.qxmd.com/read/38649834/comparison-of-bicarbonate-ringer-s-solution-with-lactated-ringer-s-solution-among-postoperative-outcomes-in-patients-with-laparoscopic-right-hemihepatectomy-a-single-centre-randomised-controlled-trial
#38
RANDOMIZED CONTROLLED TRIAL
Jie Song, Yingying Liu, Yun Li, Xiaoci Huang, Muchun Zhang, Xiaofeng Liu, Xianwen Hu
The study was aimed to investigate the positive impact of bicarbonate Ringer's solution on postoperative outcomes in patients who underwent laparoscopic right hemihepatectomy. Patients in the two groups were infused with lactated Ringer's solution (LRS, n = 38) and the bicarbonate Ringer's solution (BRS, n = 38) at a rate of 5 ml·kg-1 ·h-1 . The stroke volume was monitored and 200 ml of hydroxyethyl starch with 130/0.4 sodium chloride injection (Hes) of a bolus was given in the first 5-10 min...
April 22, 2024: BMC Anesthesiology
https://read.qxmd.com/read/38649651/assessment-of-blood-pressure-and-heart-rate-related-variables-in-acute-stroke-patients-receiving-intravenous-antihypertensive-medication-infusions
#39
JOURNAL ARTICLE
Adnan I Qureshi, William I Baskett, Abdullah Lodhi, Francisco Gomez, Niraj Arora, Premkumar N Chandrasekaran, Farhan Siddiq, Camilo R Gomez, Chi-Ren Shyu
BACKGROUND: We performed an analysis of a large intensive care unit electronic database to provide preliminary estimates of various blood pressure parameters in patients with acute stroke receiving intravenous (IV) antihypertensive medication and determine the relationship with in-hospital outcomes. METHODS: We identified the relationship between pre-treatment and post-treatment systolic blood pressure (SBP) and heart rate (HR)-related variables and in-hospital mortality and acute kidney injury in patients with acute stroke receiving IV clevidipine, nicardipine, or nitroprusside using data provided in the Medical Information Mart for Intensive Care (MIMIC) IV database...
April 22, 2024: Neurocritical Care
https://read.qxmd.com/read/38649522/ensemble-plus-final-results-of-shorter-ocrelizumab-infusion-from-a-randomized-controlled-trial
#40
JOURNAL ARTICLE
Hans-Peter Hartung, Thomas Berger, Robert A Bermel, Bruno Brochet, William M Carroll, Trygve Holmøy, Rana Karabudak, Joep Killestein, Carlos Nos, Francesco Patti, Amy Perrin Ross, Ludo Vanopdenbosch, Timothy Vollmer, Regine Buffels, Monika Garas, Karen Kadner, Marianna Manfrini, Qing Wang, Mark S Freedman
INTRODUCTION: Ocrelizumab is an approved intravenously administered anti-CD20 antibody for multiple sclerosis (MS). The safety profile and patient preference for conventional versus shorter ocrelizumab infusions were investigated in the ENSEMBLE PLUS study. METHODS: ENSEMBLE PLUS was a randomized, double-blind substudy to the single-arm ENSEMBLE study (NCT03085810), comparing outcomes in patients with early-stage relapsing-remitting MS receiving ocrelizumab 600 mg over the approved 3...
April 22, 2024: Journal of Neurology
keyword
keyword
23800
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.